Simultaneous Detection of Common Respiratory Viruses

Information

  • Research Project
  • 6694266
  • ApplicationId
    6694266
  • Core Project Number
    R43AI056861
  • Full Project Number
    1R43AI056861-01
  • Serial Number
    56861
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2003 - 21 years ago
  • Project End Date
    7/4/2004 - 20 years ago
  • Program Officer Name
    COLOMBINI-HATCH, SANDRA
  • Budget Start Date
    7/15/2003 - 21 years ago
  • Budget End Date
    7/14/2004 - 20 years ago
  • Fiscal Year
    2003
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/3/2003 - 21 years ago

Simultaneous Detection of Common Respiratory Viruses

DESCRIPTION (provided by applicant): Current diagnostic tests for viral respiratory infections provide limited clinical value and therefore rarely ordered by physicians. A rapid and accurate diagnosis enables early and effective therapeutic intervention for both common infectious pathogens and biothreat agents. The goal of this proposal is to demonstrate the feasibility of a nucleic acid-based multiplex test for the detection and quantification of the most frequently encountered viral pathogens in the respiratory tract, namely influenza A & B, parainfluenza 1,2, & 3, and respiratory syncytial virus. Conserved nucleotide sequences within each viral genome will be identified as targets for RT-PCR amplification using real-time TaqMan(R) chemistry. Each set of primers is optimized for a multiplex reaction format and will amplify with equal efficiency and similar dynamic range. The amplified products are then quantified on the Luminex xMAPTM platform, a bead-based hybridization technology capable of detecting up to 100 targets simultaneously. The unique sequence of the Taqman probe is incorporated as the capture probe on the Luminex beads. This approach combines the exquisite sensitivity of PCR with a rapid, multiplex detection system. The ultimate goal is to provide a cost-effective platform that can simultaneously and efficiently detect and quantify all types of potential pathogens.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99806
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:99806\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    INTELLIGENT MEDICAL DEVICES, INC.
  • Organization Department
  • Organization DUNS
    133581434
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02141
  • Organization District
    UNITED STATES